UNSPSC 51332521: Lenperone hydrochloride

This classification denotes an antipsychotic agent C22H23F2NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 96Q0TL6O3G, chemically known as 1-butanone, 4-(4-(4-fluorobenzoyl)-1-piperidinyl)-1-(4-fluorophenyl)-, hydrochloride (1:1), but more generally known as lenperone hydrochloride, which bears US NIH Compound Identifier 32592. European Medicines Agency schedules Lenperone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02889MIG.

UNSPSC 51332521 Lenperone hydrochloride is a Commodity code that captures pharmaceutical active ingredients and finished drug formulations procured by state and local health agencies. The recent solicitation activity under this code, however, shows a significant mismatch: Seminole County, Florida's IFB60459723LAS posted in June 2026 targets naloxone and drug deactivation systems—overdose-reversal medications and harm-reduction equipment—rather than lenperone hydrochloride specifically. The county is seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding to support community health initiatives, with quarterly deliveries to the Seminole County Community Health Building. Vendors must include all shipping and delivery costs in their proposals, maintain drug-free workplace certification and E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The initial contract term is two years with an option for one-year renewal, and the procurement carries a three-month probationary period allowing termination with or without cause. FEMA funding introduces additional federal compliance requirements, including adherence to the Clean Air Act and Federal Water Pollution Control Act. The code shows limited recent activity clearly aligned with its nominal scope; the single posted opportunity addresses naloxone procurement rather than lenperone hydrochloride.

Geographic activity under this code is concentrated in Florida, specifically Seminole County, based on the recent opportunity. No additional state or local solicitations under UNSPSC 51332521 appear in the source data. The Seminole County IFB, posted June 30, 2026 with a response deadline of July 26, 2023, represents the only documented recent state or local procurement activity. Business development professionals should note the code-scope mismatch: if pursuing pharmaceutical procurement opportunities within state and local health systems, verify whether actual buying activity aligns with the lenperone hydrochloride commodity description or whether state and local agencies are tagging broader harm-reduction and medication-management procurements under this code.